Pandemic and All-Hazards Preparedness Reauthorization Act of 2013

Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 is a significant piece of United States legislation that amended and reauthorized key public health and medical preparedness programs. It built upon the foundational Pandemic and All-Hazards Preparedness Act of 2006, enhancing the nation's ability to respond to biological threats, pandemics, and other public health emergencies. The law was designed to strengthen the medical and public health infrastructure coordinated by the Assistant Secretary for Preparedness and Response within the Department of Health and Human Services.

Background and legislative history

The impetus for this reauthorization stemmed from the impending expiration of authorities under the original Pandemic and All-Hazards Preparedness Act and lessons learned from public health incidents like the 2009 flu pandemic. Key legislative champions included Representative Mike Rogers and Senator Richard Burr, who emphasized the need for sustained investment in the Strategic National Stockpile and medical countermeasure development. The bill moved swiftly through the 113th United States Congress, passing the House with strong bipartisan support and receiving unanimous consent in the Senate. President Barack Obama signed it into law in March 2013, underscoring its importance to national health security.

Key provisions and amendments

Major provisions focused on accelerating the development and procurement of medical countermeasures like vaccines and therapeutics through enhanced collaboration between the Biomedical Advanced Research and Development Authority and entities like the Food and Drug Administration and the National Institutes of Health. It formally established the Hospital Preparedness Program to improve healthcare system readiness and strengthened the authority of the Assistant Secretary for Preparedness and Response. The act also amended the Public Health Service Act to clarify emergency use authorities for the Strategic National Stockpile and mandated the creation of a national strategy for Medical countermeasures.

Implementation and impact

Implementation was overseen primarily by the Department of Health and Human Services, which issued new guidance for state and local health departments through agencies like the Centers for Disease Control and Prevention. The act's emphasis on advanced development and manufacturing networks, such as those utilized during the 2014 Ebola response, proved critical. It provided the legal framework for the rapid deployment of resources during subsequent crises, including the Zika virus epidemic and the initial phases of the COVID-19 pandemic, particularly for the distribution of assets from the Strategic National Stockpile.

Funding and reauthorization

The legislation authorized specific funding levels for key programs, including the Hospital Preparedness Program and the Strategic National Stockpile, for fiscal years 2014 through 2018. These authorizations were intended to ensure predictable resources for long-term projects like building domestic manufacturing capacity for medical countermeasures. Subsequent legislative action, notably the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, further reauthorized and updated these programs, building on the 2013 framework to address evolving threats.

Criticism and controversy

Some criticism centered on concerns that the act did not go far enough in addressing systemic vulnerabilities, such as supply chain fragility for critical medical supplies, which became starkly apparent during the COVID-19 pandemic. Public health advocates argued that authorized funding levels were often insufficient and that subsequent appropriations by the United States Congress did not always meet the authorized amounts. Debates also occurred regarding the balance of authority between federal agencies like the Assistant Secretary for Preparedness and Response and state-level public health departments during nationwide emergencies. Category:113th United States Congress Category:United States federal public health legislation Category:2013 in American law